摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-羟基环己酮二聚物 | 60308-50-1

中文名称
2-羟基环己酮二聚物
中文别名
——
英文名称
2-hydroxycyclohexanone dimer
英文别名
adipoin;1,8-dihydroxy-9,14-dioxa-tricyclo(8.4.0.08,13)tetradecane;1,2,3,4,5a,6,7,8,9,10a-Decahydrodibenzo-p-dioxin-4a,9a-diol
2-羟基环己酮二聚物化学式
CAS
60308-50-1
化学式
C12H20O4
mdl
MFCD00151157
分子量
228.288
InChiKey
OLLWHBLCQGPTMZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    100-107 °C(lit.)
  • 沸点:
    83-86 °C13 mm Hg(lit.)
  • 密度:
    1.297±0.06 g/cm3(Predicted)
  • 闪点:
    175 °F

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    16
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    58.9
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 危险品标志:
    F,Xi
  • 海关编码:
    2932999099
  • 危险品运输编号:
    UN 1325 4.1/PG 3

SDS

SDS:3d5b64681ff6d36fca5efafdc0a90ded
查看

反应信息

  • 作为反应物:
    描述:
    2-羟基环己酮二聚物sodium periodate 作用下, 以 四氢呋喃 为溶剂, 反应 16.0h, 以80%的产率得到6-氧代己酸
    参考文献:
    名称:
    New advances in stereoselective Meyers’ lactamization. Application to the diastereoselective synthesis of β-substituted oxazoloazepinones
    摘要:
    A stereoselective approach to the preparation of 7,5-fused bicyclic lactams based on Meyers' lactamization is presented. The lactamization step is conducted at 0 degrees C with 6-oxohexanoic acid 1 and with various chiral aminoalcohols in the presence of 2-fluoro-1-ethylpyridinium tetrafluoroborate (FEP) as an activating agent. Under these mild conditions, bicyclic lactams 2-4 were obtained in satisfactory yields and diastereoselectivities Lip to 95%. To account for the high level of diastereoselection, the mechanistic aspects of Meyers' lactamization were investigated by means of in situ infrared spectroscopy. Finally, the lactam enolate derived from 2 was subjected to reaction with various electrophiles, furnishing the corresponding beta-substituted oxazoloazepinones 5-9 in good yields (up to 86%) and in moderate to excellent diastereoselectivities ranging from 27% to 95% de. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2008.10.014
  • 作为产物:
    参考文献:
    名称:
    Ring-Fused Cyclopropanone N,O-Acetals. Electrochemical Preparation and Their Reactivities under Acidic Conditions
    摘要:
    DOI:
    10.1021/jo980687u
点击查看最新优质反应信息

文献信息

  • COFERONS AND METHODS OF MAKING AND USING THEM
    申请人:Barany Francis
    公开号:US20120295874A1
    公开(公告)日:2012-11-22
    The present invention is directed to a monomer useful in preparing therapeutic compounds. The monomer includes one or more pharmacophores which potentially binds to a target molecule with a dissociation constant of less than 300 μM and a linker element connected to the pharmacophore. The linker element has a molecular weight less than 500 daltons, is connected, directly or indirectly through a connector, to the pharmacophore.
    本发明涉及一种用于制备治疗性化合物的单体。该单体包括一个或多个可与目标分子结合的药效团,其解离常数小于300微摩尔,以及与药效团连接的连接元素。所述连接元素的分子量小于500道尔顿,通过直接连接或通过连接器间接与药效团相连。
  • [EN] BENZYL-SUBSTITUTED TETRACYCLIC HETEROCYCLIC COMPOUNDS AS PDE5 INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES TÉTRACYCLIQUES À SUBSTITUTION BENZYLE COMME INHIBITEURS DE PDE5
    申请人:NYCOMED GMBH
    公开号:WO2010015589A1
    公开(公告)日:2010-02-11
    The present invention pertains to Benzyl-substituted tetracyclic heterocyclic compounds, as well as the resulting pharmaceutical compositions, and their use in the treatment or prophylaxis of diseases alleviated by inhibition of type 5 phosphodiesterases. Furthermore, the present invention pertains to the methods of manufacturing these Benzyl-substituted tetracyclic heterocyclic compounds.
    本发明涉及苄基取代的四环杂环化合物,以及由此得到的药物组合物,以及它们在治疗或预防通过抑制5型磷酸二酯酶缓解的疾病中的应用。此外,本发明涉及制造这些苄基取代的四环杂环化合物的方法。
  • [EN] AZAINDOLE COMPOUNDS AND METHODS FOR TREATING HIV<br/>[FR] COMPOSÉS D'AZA-INDOLE ET PROCÉDÉS POUR TRAITER LE VIH
    申请人:GLAXOSMITHKLINE LLC
    公开号:WO2013012649A1
    公开(公告)日:2013-01-24
    Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
    提供的是化合物及其药用盐,它们的药物组合物,它们的制备方法,以及它们用于治疗由逆转录病毒家族成员介导的病毒感染,如人类免疫缺陷病毒(HIV)的用途。
  • Chemoselective Pd-Catalyzed Oxidation of Polyols: Synthetic Scope and Mechanistic Studies
    作者:Kevin Chung、Steven M. Banik、Antonio G. De Crisci、David M. Pearson、Timothy R. Blake、Johan V. Olsson、Andrew J. Ingram、Richard N. Zare、Robert M. Waymouth
    DOI:10.1021/ja4008694
    日期:2013.5.22
    9-dimethyl-1,10-phenanthroline) occurs readily under mild reaction conditions to generate α-hydroxy ketones. The oxidation of vicinal diols is both faster and more selective than the oxidation of primary and secondary alcohols; vicinal 1,2-diols are oxidized selectively to hydroxy ketones, whereas primary alcohols are oxidized in preference to secondary alcohols. Oxidative lactonization of 1,5-diols yields
    在温和的反应条件下,未保护的邻位多元醇与 [(neocuproine)Pd(OAc)]2(OTf)2 (1)(neocuproine = 2,9-二甲基-1,10-菲咯啉)的区域和化学选择性氧化很容易发生生成α-羟基酮。邻二醇的氧化比伯醇和仲醇的氧化速度更快,选择性更强;邻位 1,2-二醇被选择性氧化为羟基酮,而伯醇优先于仲醇氧化。1,5-二醇的氧化内酯化产生环内酯。在 10 克规模的氧化反应中,可以使用低至 0.12 mol% 的催化剂负载量。在多元醇 (S,S)-1,2,3,4-四羟基丁烷 [(S,S)-苏糖醇] 到 (S)-赤藓酮糖的化学选择性和立体定向氧化过程中,该催化剂体系的卓越选择性是显而易见的。机械的,动力学和理论研究表明,伯醇和仲醇的氧化速率定律与二醇不同。密度泛函理论计算支持以下结论:β-氢化物消除产生羟基酮是邻二醇氧化的产物决定因素,而对于伯醇和仲醇,有利于伯醇盐的预平
  • 6-Benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds useful as PDE5 inhibitors
    申请人:Nycomed GmbH
    公开号:EP1953159A1
    公开(公告)日:2008-08-06
    The compounds of formula (I) wherein R1 to R8 and R11 have the meanings as given in the description, the salts thereof, the N-oxides of the compounds and the salts thereof, and the stereoisomers of the compounds, the salts, the N-oxides of the compounds and the N-oxides of the salts thereof are effective inhibitors of the type 5 phosphodiesterase.
    式(I)中的化合物,其中R1至R8和R11的含义如描述中所示,其盐,化合物的N-氧化物及其盐,化合物的立体异构体,盐,化合物的N-氧化物及其盐的N-氧化物是有效的第5型磷酸二酯酶抑制剂。
查看更多

同类化合物

(2S,4aR,5S,8R,8aR)-8-乙基-4a,5-二羟基-六氢-2H-2,5-环氧色素-4(3H)-酮 阿斯利多 锗(II)氯化二噁烷络合物 试剂5-Methyl-5-propargyloxycarbonyl-1,3-dioxane-2-one 螺二醇 螺[环丙烷-1,7'-[2,3]二氧杂双环[2.2.1]庚烷] 螺[3,6-二氧杂双环[3.1.0]己烷-2,4'-咪唑烷] 薰衣草恶烷 苯乙醛 1,3-丙烷二基缩醛 脱水莫诺苷元 硫脲与2,4,8,10-四氧杂螺[5.5]十一烷-3,9-丙二胺和缩水甘油丁醚的反应产物 硝溴生 盐酸大观霉素 盐酸1,4-二恶烷 甲基 2,3-脱水-beta-D-呋喃核糖苷 甘油缩甲醛 溴化[5-(羟甲基)-2-苯基-1,3-二噁烷-5-基]-N,N,N-三甲基甲铵 溴[4-(1,3-二恶烷-2-基)苯基]镁 溴[3-(1,3-二恶烷-2-基)苯基]镁 溴[2-(1,3-二恶烷-2-基)苯基]镁 溴-1,4-二氧六环复合物 氯甲基聚苯乙烯 敌噁磷 戊氧氯醛 对二恶烷-2,6-二甲醇 奇烯醇霉素 大观霉素 埃玛菌素 吡啶,2-(1,3-二噁烷-2-基)- 反式-5-溴-4-苯基-[1,3]二恶烷 反式-2,5-双-(羟甲基)-1,4-二恶烷 双(4-乙基亚苯基)山梨醇 六氢[1,4]二恶英并[2,3-b]-1,4-二恶英 六氢-2,4,4,7-四甲基-4H-1,3-苯并二氧杂环己 全氟(2-氧代-3,6-二甲基-1,4-二恶烷) 亚苄基-2,2-双(氧基甲基)丙酸 二苯并[b,e][1,4]二噁英,4a,5a,9a,10a-四氢-,溴化氯化(1:2:6) 二苯并[b,e][1,4]二噁英,4a,5a,9a,10a-四氢-,溴化氯化(1:2:5) 二聚丁醇醛 二甲基二恶烷 二甲基2,4:3,5-二-O-亚甲基-D-葡萄糖二酸 二甲基2,4,8,10-四氧杂螺[5.5]十一烷-3,9-二羧酸酯 二甲基-1,4-二恶烷 二甘醇酐 二环[3.1.0]己烷-3-酮,4-亚甲基-1-(1-甲基乙基)-,肟 二氯硼烷二氧六环 二氧六环-d8 二氢壮观霉素 二恶烷 二噁烷甘醇